These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Luo W; Wang Y; Reiser G Brain Res Rev; 2007 Dec; 56(2):331-45. PubMed ID: 17915333 [TBL] [Abstract][Full Text] [Related]
28. Protease-activated receptors: protease signaling in the gastrointestinal tract. Amadesi S; Bunnett N Curr Opin Pharmacol; 2004 Dec; 4(6):551-6. PubMed ID: 15525542 [TBL] [Abstract][Full Text] [Related]
30. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Wang H; Ubl JJ; Reiser G Glia; 2002 Jan; 37(1):53-63. PubMed ID: 11746783 [TBL] [Abstract][Full Text] [Related]
32. Thrombin receptor: An endogenous inhibitor of inflammatory pain, activating opioid pathways. Martin L; Augé C; Boué J; Buresi MC; Chapman K; Asfaha S; Andrade-Gordon P; Steinhoff M; Cenac N; Dietrich G; Vergnolle N Pain; 2009 Nov; 146(1-2):121-9. PubMed ID: 19674841 [TBL] [Abstract][Full Text] [Related]
33. Role of protease-activated receptor-2 in inflammation, and its possible implications as a putative mediator of periodontitis. Holzhausen M; Spolidorio LC; Vergnolle N Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():177-80. PubMed ID: 15962119 [TBL] [Abstract][Full Text] [Related]
34. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors. Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460 [TBL] [Abstract][Full Text] [Related]
36. The cardiovascular actions of protease-activated receptors. Steinberg SF Mol Pharmacol; 2005 Jan; 67(1):2-11. PubMed ID: 15371558 [TBL] [Abstract][Full Text] [Related]
37. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167 [TBL] [Abstract][Full Text] [Related]
38. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. Uehara A; Muramoto K; Takada H; Sugawara S J Immunol; 2003 Jun; 170(11):5690-6. PubMed ID: 12759451 [TBL] [Abstract][Full Text] [Related]
39. Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Ubl JJ; Vöhringer C; Reiser G Neuroscience; 1998 Sep; 86(2):597-609. PubMed ID: 9881872 [TBL] [Abstract][Full Text] [Related]
40. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Ramachandran R; Hollenberg MD Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S263-82. PubMed ID: 18059329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]